Temolina is an oral antidiabetic medicine used for the management of type 2 diabetes mellitus in adults. It belongs to the DPP-4 inhibitor class and works by enhancing the activity of incretin hormones, which help regulate blood glucose levels by increasing insulin release and decreasing excess glucagon secretion in a glucose-dependent manner. Temolina supports effective glycemic control without significant fluctuations in blood sugar levels and is commonly used alongside diet, exercise, and other lifestyle modifications. It may be prescribed alone or in combination with other antidiabetic agents when additional glucose control is needed. By helping maintain stable blood sugar levels, Temolina contributes to reducing the risk of long-term diabetes-related complications and supports improved metabolic health and overall quality of life.